Reven Holdings
Reven Pharmaceuticals: A global healthcare leader providing advanced treatments for vascular and metabolic conditions since 1999.
Founded
1999Reven Pharmaceuticals: A global healthcare leader providing advanced treatments for vascular and metabolic conditions since 1999.
Reven Holdings, founded in 1999 and headquartered in Golden, Colorado, is a clinical-stage company dedicated to providing advanced treatments for vascular and metabolic-related conditions. The company's core mission is to develop innovative solutions that enhance patient recovery and improve outcomes for conditions such as critical limb ischemia, peripheral arterial disease, coronary artery disease, and endothelial dysfunction. Reven Pharmaceuticals positions itself as a global healthcare leader with a strong focus on delivering cutting-edge products to address these serious health issues.
Notable figures affiliated with Reven Holdings include its leadership team, which comprises experienced professionals in healthcare and pharmaceuticals. The company has garnered attention from significant investors in the biotech sector, contributing to its growth and development. Key achievements include advancing its pipeline of therapeutic products through various stages of clinical trials, demonstrating potential efficacy in treating complex vascular and metabolic conditions. Reven's impact is marked by its commitment to improving patient care and its ongoing contributions to medical research and innovation.
Companies similar to Reven Holdings include Revvity, Revagenix, Rivus Pharmaceuticals and Revance Therapeutics.
Reven Holdings was founded in 1999.
Reven Holdings' headquarters is located in Broomfield, CO, US.
Reven Holdings' most recent funding round was for $23M (USD) in January 2019.
As of Jan 1, 2019, Reven Holdings has raised a total of $67.3M (USD).
Reven Holdings has 6 employees as of Feb 5, 2024.
Rivus Pharmaceuticals
rivuspharma.com
